Add Yahoo as a preferred source to see more of our stories on Google. Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human ...
Everyday Health on MSN
Making the switch: Moving from IVIg to SCIg for CIDP
Learn about switching from IVIg to SCIg for CIDP, including benefits, barriers, and support for home-based subcutaneous ...
The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...
Sanofi's subcutaneous formulation of multiple myeloma drug Sarclisa has been approved in the UK, which will be the first market for the on-body injector (OBI) version of the drug.
A Massachusetts Institute of Technology team first kicked off work on its syringe after speaking with the Bill & Melinda Gates Foundation about the need for easier vaccination options in developing ...
Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injectorSarclisa administered via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results